9
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T13550 | AP5 | Others | |
AP5 is a potent and selective agonist for the GPR40 receptor with positive allosteric modulation of endogenous ligands (AgoPAM). AP5 demonstrates a rat hIP1 EC50 of 0.49 nM against the GPR40 receptor. | |||
T10930 | D-AP5 | D-APV,D-2-Amino-5-phosphonovaleric acid | NMDAR , iGluR |
D-AP5 (D-APV) is a NMDA receptor antagonist. | |||
T22733 | DL-AP5 | NMDAR | |
DL-AP5 is the racemic form of a selective N-methyl-D-aspartate (NMDA) receptor antagonist with anticonvulsant effects. | |||
T22909 | L-AP5 | Others | |
L-AP5 is a NMDA antagonist. | |||
T23081 | NPEC-caged-D-AP5 | Others | |
NPEC-caged-D-AP5 is a NMDA receptor antagonist. | |||
T22732 | DL-AP5 Sodium salt | Others | |
DL-AP5 Sodium salt is a NMDA receptor antagonist. | |||
T63202 | AP5 sodium | ||
AP5 sodium is a selective, potent, orally active GPR40 receptor agonist that exhibits positive allosteric modulation of endogenous ligands (AgoPAM). sodium exhibits potential for the study of type II diabetes. | |||
T16831 | (S)-SNAP5114 | Others , GABA Receptor | |
(S)-SNAP5114 is a selective inhibitor of GABA transport with IC50s of 5 μM for hGAT-3 and 21 μM for rGAT-2. (S)-SNAP5114 has anticonvulsant properties. | |||
T10344 | AP521 | 5-HT Receptor | |
AP521 is an agonist of the human 5-HT1A receptor (IC50: 94 nM). |